NEW YORK (360DX) – French in vitro diagnostic firm Eurobio Scientific announced on Monday the acquisition of antibody development and production company Dendritics, also French, for undisclosed terms.

The deal was completed in cash with "no significant impact" on Eurobio's cash position, according to the firm.

Based in Lyon, Dendritics develops antibodies against immune system and other cells for the discovery of targets with high diagnostic, prognostic, and therapeutic potential. The company posted about €350,000 ($410,000) in revenues in 2017, Eurobio said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.